Xenon Pharmaceuticals (XENE) Insider Trading & Ownership $39.73 +0.35 (+0.89%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$39.73 0.00 (0.00%) As of 02/21/2025 06:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Xenon Pharmaceuticals (NASDAQ:XENE) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage5.52%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)5Amount OfInsider Selling(Last 12 Months)$3.47 M Get XENE Insider Trade Alerts Want to know when executives and insiders are buying or selling Xenon Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address XENE Insider Buying and Selling by Quarter Xenon Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails1/27/2025Ian MortimerCEOSell16,315$40.50$660,757.50 1/24/2025Ian MortimerCEOSell22,468$40.20$903,213.60 12/18/2024Sherry AulinCFOSell18,709$41.21$770,997.89 11/22/2024Gary PatouDirectorSell4,891$41.08$200,922.28 3/7/2024Sherrington RobinEVPSell7,137$46.28$330,300.36 3/7/2024Steven GannonDirectorSell13,000$46.28$601,640.00 (Data available from 1/1/2013 forward) XENE Insider Trading Activity - Frequently Asked Questions Who is on Xenon Pharmaceuticals's Insider Roster? The list of insiders at Xenon Pharmaceuticals includes Christopher John Kenney, Dawn Svoronos, Gary Patou, Ian Mortimer, James R Empfield, Sherrington Robin, Sherry Aulin, Simon N Pimstone, and Steven Gannon. Learn more on insiders at XENE. What percentage of Xenon Pharmaceuticals stock is owned by insiders? 5.52% of Xenon Pharmaceuticals stock is owned by insiders. Learn more on XENE's insider holdings. Which Xenon Pharmaceuticals insiders have been selling company stock? The following insiders have sold XENE shares in the last 24 months: Christopher John Kenney ($24,507.00), Dawn Svoronos ($967,500.00), Gary Patou ($648,042.48), Ian Mortimer ($2,874,804.65), Sherrington Robin ($330,300.36), Sherry Aulin ($770,997.89), Simon N Pimstone ($3,130,955.56), and Steven Gannon ($601,640.00). How much insider selling is happening at Xenon Pharmaceuticals? Insiders have sold a total of 233,013 Xenon Pharmaceuticals shares in the last 24 months for a total of $9,348,747.94 sold. Xenon Pharmaceuticals Key ExecutivesMr. Ian C. Mortimer C.M.A. (Age 48)CPA, M.B.A., President, CEO & Director Compensation: $1.07MMs. Sherry Aulin C.A. (Age 41)CPA, Chief Financial Officer Compensation: $664.8k1 recent tradesDr. Robin P. Sherrington Ph.D. (Age 63)Executive Vice President of Strategy & Innovation Compensation: $587.03kDr. Christopher E. Von Seggern M.B.A. (Age 45)M.P.H., M.P.H. M.B.A, Ph.D., Chief Commercial Officer Compensation: $621.12kDr. Christopher John Kenney M.D. (Age 53)Chief Medical Officer Compensation: $719.82kMs. Andrea DiFabio J.D. (Age 56)Chief Legal Officer & Corporate Secretary Compensation: $200.51kMs. Shelley McCloskey B.A. (Age 64)Executive Vice President of Human Resources Dr. James R. Empfield Ph.D. (Age 63)Executive Vice President of Drug Discovery Compensation: $323.43kMs. Sheila M. Grant M.B.A.M.Sc., MBA, Executive Vice President of R&D Operations More Insider Trading Tools from MarketBeat Related Companies PCVX Insider Transactions SRPT Insider Transactions ROIV Insider Transactions RVMD Insider Transactions BBIO Insider Transactions AXSM Insider Transactions BPMC Insider Transactions ELAN Insider Transactions LNTH Insider Transactions NUVL Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 3 Stocks With Robust Growth Outlooks Insiders Are BuyingMETA Stock: Insider Selling Ramps Up—What It Means for InvestorsThese Are the Dividend Stocks Insiders Bought in JanuaryInsider Selling in Tech Stocks Spikes in Q43 Small-Cap Stocks Insiders and Institutions Are Buying This page (NASDAQ:XENE) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | Sponsored[RFK Jr CONFIRMED] Here’s why Dems are TERRIFIEDRobert F. Kennedy Jr was just confirmed as Trump’s secretary of Health and Human Services… but it was NOT easy...NewMarket Health Publishing, LLC. | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredWhy Buffett and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredShocking Elon Move: Bigger than DOGE?After saving free speech with his acquisition of Twitter… And after blowing everyone’s minds with his recen...Brownstone Research | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Xenon Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Xenon Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free XENE Stock Alerts